John Barthelow Classen

Dendritic cell–expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice

Measles Vaccination and Inflammatory Bowel Disease: A National British Cohort Study

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel

Hepatitis B Virus Infection: Epidemiology and Vaccination

A Comprehensive Review of Interventions in the NOD Mouse and Implications for Translation

Vaccinia scars associated with better survival for adults

Crohn's disease

TFOS DEWS II pathophysiology report

The Hygiene Hypothesis: An Explanation for the Increased Frequency of Insulin-Dependent Diabetes

Type 1 diabetes

Effects of immunosuppressive drugs during pregnancy

Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences

Potential health effects from non‐specific stimulation of the immune function in early age: The example of BCG vaccination

Diversity, stability and resilience of the human gut microbiota

Defining trained immunity and its role in health and disease

Vaccine hesitancy

Vaccine safety: risk communication — a global perspective

Dendritic cells with TGF-β1 differentiate naïve CD4⁺CD25⁻T cells into islet-protective Foxp3⁺regulatory T cells

Childhood Vaccinations, Vaccination Timing, and Risk of Type 1 Diabetes Mellitus

The Timing of Immunization Affects the Development of Diabetes in Rodents

Clustering of Cases of Type 1 Diabetes Mellitus Occurring 2-4 Years After Vaccination is Consistent with Clustering After Infections and Progression to Type I Diabetes Mellitus in Autoantibody Positive Individuals

EVIDENCE THAT CYCLOSPORINE TREATMENT DURING PREGNANCY PREDISPOSES OFFSPRING TO DEVELOP AUTOANTIBODIES

The Timing of Pediatric Immunization and the Risk of Insulin-Dependent Diabetes Mellitus

Immunization in the First Month of Life may Explain Decline in Incidence of IDDM in the Netherlands